Literature DB >> 27601210

Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C.

Eyal Reinstein1,2, Ana Gutierrez-Fernandez3, Shay Tzur4,5, Concetta Bormans6, Shai Marcu7, Einav Tayeb-Fligelman8, Chana Vinkler9, Annick Raas-Rothschild2,10, Dana Irge11, Meytal Landau8, Mordechai Shohat2,12, Xose S Puente3, Doron M Behar6, Carlos Lopez-Otın3.   

Abstract

In the vast majority of pediatric patients with dilated cardiomyopathy, the specific etiology is unknown. Studies on families with dilated cardiomyopathy have exemplified the role of genetic factors in cardiomyopathy etiology. In this study, we applied whole-exome sequencing to members of a non-consanguineous family affected by a previously unreported congenital dilated cardiomyopathy syndrome necessitating early-onset heart transplant. Exome analysis identified compound heterozygous variants in the FLNC gene. Histological analysis of the cardiac muscle demonstrated marked sarcomeric and myofibrillar abnormalities, and immunohistochemical staining demonstrated the presence of Filamin C aggregates in cardiac myocytes. We conclude that biallelic variants in FLNC can cause congenital dilated cardiomyopathy. As the associated clinical features of affected patients are mild, and can be easily overlooked, testing for FLNC should be considered in children presenting with dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27601210      PMCID: PMC5117915          DOI: 10.1038/ejhg.2016.110

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  Mouse model of desmin-related cardiomyopathy.

Authors:  X Wang; H Osinska; G W Dorn; M Nieman; J N Lorenz; A M Gerdes; S Witt; T Kimball; J Gulick; J Robbins
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

2.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.

Authors:  X Wang; H Osinska; R Klevitsky; A M Gerdes; M Nieman; J Lorenz; T Hewett; J Robbins
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

3.  Mutations in TAX1BP3 cause dilated cardiomyopathy with septo-optic dysplasia.

Authors:  Eyal Reinstein; Katia Orvin; Einav Tayeb-Fligelman; Hadas Stiebel-Kalish; Shay Tzur; Allen L Pimienta; Lily Bazak; Tuvia Bengal; Lior Cohen; Dan D Gaton; Concetta Bormans; Meytal Landau; Ran Kornowski; Mordechai Shohat; Doron M Behar
Journal:  Hum Mutat       Date:  2015-03-16       Impact factor: 4.878

Review 4.  Inherited cardiomyopathies.

Authors:  Jeffrey A Towbin
Journal:  Circ J       Date:  2014-09-02       Impact factor: 2.993

5.  Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.

Authors:  I Dalkilic; J Schienda; T G Thompson; L M Kunkel
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 6.  The genetics of dilated cardiomyopathy.

Authors:  Lisa Dellefave; Elizabeth M McNally
Journal:  Curr Opin Cardiol       Date:  2010-05       Impact factor: 2.161

7.  Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro.

Authors:  Misato Fujita; Hiroaki Mitsuhashi; Sumio Isogai; Takahiro Nakata; Atsushi Kawakami; Ikuya Nonaka; Satoru Noguchi; Yukiko K Hayashi; Ichizo Nishino; Akira Kudo
Journal:  Dev Biol       Date:  2011-10-14       Impact factor: 3.582

8.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes.

Authors:  Adam Siepel; Gill Bejerano; Jakob S Pedersen; Angie S Hinrichs; Minmei Hou; Kate Rosenbloom; Hiram Clawson; John Spieth; Ladeana W Hillier; Stephen Richards; George M Weinstock; Richard K Wilson; Richard A Gibbs; W James Kent; Webb Miller; David Haussler
Journal:  Genome Res       Date:  2005-07-15       Impact factor: 9.043

9.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy.

Authors:  Andreas Brodehl; Raechel A Ferrier; Sara J Hamilton; Steven C Greenway; Marie-Anne Brundler; Weiming Yu; William T Gibson; Margaret L McKinnon; Barbara McGillivray; Nanette Alvarez; Michael Giuffre; Jeremy Schwartzentruber; Brenda Gerull
Journal:  Hum Mutat       Date:  2016-01-08       Impact factor: 4.878

10.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy.

Authors:  Rachael M Duff; Valerie Tay; Peter Hackman; Gianina Ravenscroft; Catriona McLean; Paul Kennedy; Alina Steinbach; Wiebke Schöffler; Peter F M van der Ven; Dieter O Fürst; Jaeguen Song; Kristina Djinović-Carugo; Sini Penttilä; Olayinka Raheem; Katrina Reardon; Alessandro Malandrini; Simona Gambelli; Marcello Villanova; Kristen J Nowak; David R Williams; John E Landers; Robert H Brown; Bjarne Udd; Nigel G Laing
Journal:  Am J Hum Genet       Date:  2011-05-27       Impact factor: 11.025

View more
  19 in total

Review 1.  Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.

Authors:  Han-Chih Hencher Lee; Chor-Kwan Ching
Journal:  Clin Biochem Rev       Date:  2019-11

2.  Kettin, the large actin-binding protein with multiple immunoglobulin domains, is essential for sarcomeric actin assembly and larval development in Caenorhabditis elegans.

Authors:  Kanako Ono; Zhaozhao Qin; Robert C Johnsen; David L Baillie; Shoichiro Ono
Journal:  FEBS J       Date:  2019-08-24       Impact factor: 5.542

Review 3.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

4.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy.

Authors:  Nathan R Tucker; Micheal A McLellan; Dongjian Hu; Jiangchuan Ye; Victoria A Parsons; Robert W Mills; Sebastian Clauss; Elena Dolmatova; Marisa A Shea; David J Milan; Nandita S Scott; Mark Lindsay; Steven A Lubitz; Ibrahim J Domian; James R Stone; Honghuang Lin; Patrick T Ellinor
Journal:  Circ Cardiovasc Genet       Date:  2017-12

5.  FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling.

Authors:  Anastasia Knyazeva; Aleksandr Khudiakov; Raquel Vaz; Aleksey Muravyev; Ksenia Sukhareva; Thomas Sejersen; Anna Kostareva
Journal:  Genes (Basel)       Date:  2020-11-13       Impact factor: 4.096

6.  Loss of Filamin C Is Catastrophic for Heart Function.

Authors:  Yangzhao Zhou; Ze'e Chen; Lunfeng Zhang; Mason Zhu; Changming Tan; Xinmin Zhou; Sylvia M Evans; Xi Fang; Wei Feng; Ju Chen
Journal:  Circulation       Date:  2020-03-09       Impact factor: 29.690

7.  ZBTB17 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Authors:  Yu-Min Sun; Jun Wang; Ying-Jia Xu; Xin-Hua Wang; Fang Yuan; Hua Liu; Ruo-Gu Li; Min Zhang; Yan-Jie Li; Hong-Yu Shi; Liang Zhao; Xing-Biao Qiu; Xin-Kai Qu; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-02-14       Impact factor: 1.814

8.  Identification of MYLK3 mutations in familial dilated cardiomyopathy.

Authors:  Takashige Tobita; Seitaro Nomura; Hiroyuki Morita; Toshiyuki Ko; Takanori Fujita; Haruhiro Toko; Kenta Uto; Nobuhisa Hagiwara; Hiroyuki Aburatani; Issei Komuro
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

9.  Clinical exome sequencing revealed that FLNC variants contribute to the early diagnosis of cardiomyopathies in infant patients.

Authors:  Feifan Xiao; Qiufen Wei; Bingbing Wu; Xu Liu; Aiyao Mading; Lin Yang; Yan Li; Fang Liu; Xinnian Pan; Huijun Wang
Journal:  Transl Pediatr       Date:  2020-02

10.  A mutation update for the FLNC gene in myopathies and cardiomyopathies.

Authors:  Job A J Verdonschot; Els K Vanhoutte; Godelieve R F Claes; Apollonia T J M Helderman-van den Enden; Janneke G J Hoeijmakers; Debby M E I Hellebrekers; Amber de Haan; Imke Christiaans; Ronald H Lekanne Deprez; Hanne M Boen; Emeline M van Craenenbroeck; Bart L Loeys; Yvonne M Hoedemaekers; Carlo Marcelis; Marlies Kempers; Esther Brusse; Jaap I van Waning; Annette F Baas; Dennis Dooijes; Folkert W Asselbergs; Daniela Q C M Barge-Schaapveld; Pieter Koopman; Arthur van den Wijngaard; Stephane R B Heymans; Ingrid P C Krapels; Han G Brunner
Journal:  Hum Mutat       Date:  2020-03-20       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.